Norges Bank’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-4,000
Closed -$629K 2138
2018
Q4
$629K Buy
+4,000
New +$596K ﹤0.01% 2066

Other funds holding ORTX

Norges Bank's ORTX Position: Q1 2019 in Review

Norges Bank sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2019, closing a stake of 4,000 shares — an estimated $629K sold.

Norges Bank first reported a position in ORTX in Q4 2018 and held it in 1 quarter. The position peaked at $629K in Q4 2018. 43 funds tracked by Wall St. Rank hold ORTX as of Q1 2019.

  • Norges Bank reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2019 after selling out during the quarter.
  • Norges Bank sold 4,000 Orchard Therapeutics plc American Depositary Shares shares in Q1 2019, an estimated $629K.
  • Norges Bank first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 1 quarter.
  • Norges Bank's Orchard Therapeutics plc American Depositary Shares position peaked at $629K in Q4 2018.
  • 43 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2019.

Based on Norges Bank's 13F filing for Q1 2019, filed 9 May 2019.